Harrow Health ( (HROW) ) has released a notification of late filing.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Harrow Health has announced a delay in filing its Form 10-K (Yearly Report) for the fiscal year ending December 31, 2024. The primary reasons for this delay include the need for additional time to perform certain accounting analyses, complete management’s evaluation of internal controls over financial reporting, and prepare certain disclosures. The company anticipates filing the report within 15 calendar days following the prescribed due date. Harrow Health does not expect any changes to its preliminary unaudited financial results for the full year and fourth quarter of 2024, as previously announced. The company remains committed to compliance, with Chief Financial Officer Andrew R. Boll signing the notification.
More about Harrow Health
YTD Price Performance: -37.06%
Average Trading Volume: 352,210
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $819.5M
Find detailed analytics on HROW stock on TipRanks’ Stock Analysis page.